𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biomarkers for Parkison's disease: Tools to assess Parkinson's disease onset and progression

✍ Scribed by Kenneth Marek; Danna Jennings; Gilles Tamagnan; John Seibyl

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
130 KB
Volume
64
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

UnitΓ© Rhumatologique des Affections de l
UnitΓ© Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren's disease–specific disability
✍ Johann Beaudreuil; Anne Allard; Djamila Zerkak; Robert A. Gerber; Joseph C. Capp πŸ“‚ Article πŸ“… 2011 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 124 KB

## Abstract ## Objective To our knowledge, no functional outcome measure has been developed and validated for Dupuytren's disease. We aimed to develop and validate a patient‐reported functional outcome measure for Dupuytren's disease. ## Methods Patients with Dupuytren's disease (n = 9) and medi

Comparison between the decrease of dopam
Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models
✍ Yasushi Ito; Masahiro Fujita; Shoichi Shimada; Yoshiyuki Watanabe; Tomoya Okada; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 1 views

Early diagnosis of Parkinson's disease (PD) is important for the potential application of neuroprotective therapies. The purpose of this study was to assess the detection of the early changes of PD by either imaging the dopamine transporter (DAT) or uptake of L-3,4-dihydroxyphenylalanine (L-DOPA). A